Comparison of Intravenous Dexmedetomidine, Ketamine, and Preservative-Free Lignocaine for Attenuation of Propofol Injection Pain: Randomized, Double-Blind Study
Sri Lankan Journal of Anaesthesiology · 20.11.2026 · 34 (3) · 436-443
DOI: 10.4038/slja.v34i3.9933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sri Lankan Journal of Anaesthesiology, online erschienen am 20.11.2026. Verfasst von Kumar Ashok Sanju und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aims: Pain on propofol injection (POPI) occurs in 28%–98% of patients and remains a significant clinical drawback. Preservative-free lignocaine is widely used but fails in 13%–32% of cases. This study compared the efficacy of intravenous dexmedetomidine (0.25 mcg/kg), ketamine (0.2 mg/kg), and lignocaine (0.5 mg/kg) in alleviating POPI and their effects on haemodynamic parameters.
Methods
In this prospective, randomised, double-blind study, 150 ASA I–II patients (18–60 years) scheduled for elective surgery were randomised 1:1:1 into Group D (dexmedetomidine), Group K (ketamine), and Group L (lignocaine), n = 50 each. Study drugs were administered over 10 seconds following venous occlusion at 90 mmHg for 60 seconds. POPI severity was assessed using the McCrirrick and Hunter scale at 0, 30, and 60 seconds. Haemodynamic parameters were recorded at baseline, pre-induction, and one-minute post-induction.
Results
Median POPI scores were 0, 1, and 0 for Groups D, K, and L, respectively, at all time points (p < 0.001). Blood pressure and heart rate declined progressively in Group D (p < 0.001) and rose progressively in Group K (p < 0.001), while Group L maintained haemodynamic stability across all parameters (SBP p = 0.051; DBP p = 0.080; MAP p = 0.385). Peripheral oxygen saturation remained above 97% in all groups with no significant inter-group difference (p = 0.327).
Conclusion
Both dexmedetomidine and lignocaine effectively alleviate POPI. Preservative-free lignocaine demonstrates superior haemodynamic stability and remains the preferred agent for routine clinical use. Dexmedetomidine is a viable alternative where mild sympatholysis is clinically acceptable.
Zitieren
APA
Sanju, K. A., Manasa, S., & Shivananda, B. T. P. (2026). Comparison of Intravenous Dexmedetomidine, Ketamine, and Preservative-Free Lignocaine for Attenuation of Propofol Injection Pain: Randomized, Double-Blind Study. Sri Lankan Journal of Anaesthesiology, 34(3), 436-443. https://doi.org/10.4038/slja.v34i3.9933
Vancouver
Sanju KA, Manasa S, Shivananda BTP. Comparison of Intravenous Dexmedetomidine, Ketamine, and Preservative-Free Lignocaine for Attenuation of Propofol Injection Pain: Randomized, Double-Blind Study. Sri Lankan Journal of Anaesthesiology. 2026;34(3):436-443. doi:10.4038/slja.v34i3.9933
BibTeX
@article{Sanju2026,
author = {Sanju, Kumar Ashok and Manasa, Shekar and Shivananda, Bhatt T. P.},
title = {Comparison of Intravenous Dexmedetomidine, Ketamine, and Preservative-Free Lignocaine for Attenuation of Propofol Injection Pain: Randomized, Double-Blind Study},
journal = {Sri Lankan Journal of Anaesthesiology},
year = {2026},
volume = {34},
number = {3},
pages = {436--443},
doi = {10.4038/slja.v34i3.9933}
}
EUVIMED